158 related articles for article (PubMed ID: 29890234)
1. Principles and practice of high-dose rate penile brachytherapy: Planning and delivery techniques.
Parsai S; Cherian S; Berglund RK; Lee B; Kolar M; Nagle-Hernan N; Wilkinson A; Ciezki J
Pract Radiat Oncol; 2018; 8(6):e386-e391. PubMed ID: 29890234
[TBL] [Abstract][Full Text] [Related]
2. Penile brachytherapy: results for 49 patients.
Crook JM; Jezioranski J; Grimard L; Esche B; Pond G
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):460-7. PubMed ID: 15890588
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate interstitial brachytherapy for the treatment of penile carcinoma.
Petera J; Odrázka K; Zouhar M; Bedrosová J; Dolezel M
Strahlenther Onkol; 2004 Feb; 180(2):123-5. PubMed ID: 14762666
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate brachytherapy for localized penile cancer: Evolution of a technique.
Marbán M; Crook J; Keyes M; Dubash R; Batchelar D
Brachytherapy; 2020; 19(2):201-209. PubMed ID: 31959520
[TBL] [Abstract][Full Text] [Related]
5. Optimized penile surface mold brachytherapy using latest stereolithography techniques: A single-institution experience.
D'Alimonte L; Ravi A; Helou J; Morrison D; Mendez LC; Easton H; Morton G
Brachytherapy; 2019; 18(3):348-352. PubMed ID: 30718175
[TBL] [Abstract][Full Text] [Related]
6. Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients).
Cordoba A; Escande A; Lopez S; Mortier L; Mirabel X; Coche-Déqueant B; Lartigau E
Radiat Oncol; 2016 Jul; 11():96. PubMed ID: 27464910
[TBL] [Abstract][Full Text] [Related]
7. Organ-sparing treatment of penile cancer with interstitial pulsed-dose-rate brachytherapy.
Seibold J; Strnad V; Fietkau R
Strahlenther Onkol; 2016 Jul; 192(7):467-72. PubMed ID: 27276876
[TBL] [Abstract][Full Text] [Related]
8. [Brachytherapy for penile carcinoma].
Blanchard P; Delannes M; Haie-Meder C
Cancer Radiother; 2013 Apr; 17(2):140-2. PubMed ID: 23490170
[TBL] [Abstract][Full Text] [Related]
9. Interstitial brachytherapy for penile cancer: an alternative to amputation.
Crook J; Grimard L; Tsihlias J; Morash C; Panzarella T
J Urol; 2002 Feb; 167(2 Pt 1):506-11. PubMed ID: 11792907
[TBL] [Abstract][Full Text] [Related]
10. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
11. Nineteen-year single-center experience in 76 patients with penile cancer treated with high-dose-rate brachytherapy.
Kellas-Ślęczka S; Białas B; Fijałkowski M; Wojcieszek P; Szlag M; Cholewka A; Wesołowski M; Ślęczka M; Krzysztofiak T; Larysz D; Kołosza Z; Trzaska K; Pruefer A
Brachytherapy; 2019; 18(4):493-502. PubMed ID: 31101437
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX).
de Crevoisier R; Slimane K; Sanfilippo N; Bossi A; Albano M; Dumas I; Wibault P; Fizazi K; Gerbaulet A; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1150-6. PubMed ID: 19395183
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate interstitial brachytherapy for T1-T2-stage penile carcinoma: short-term results.
Sharma DN; Joshi NP; Gandhi AK; Haresh KP; Gupta S; Julka PK; Rath GK
Brachytherapy; 2014; 13(5):481-7. PubMed ID: 25037912
[TBL] [Abstract][Full Text] [Related]
14. Penile brachytherapy-Retrospective review of a single institution.
Pimenta A; Gutierrez C; Mosquera D; Pera J; Martínez E; Londres B; Pino F; Moreno S; Garcia M; Guedea F
Brachytherapy; 2015; 14(4):525-30. PubMed ID: 25863414
[TBL] [Abstract][Full Text] [Related]
15. Organ sparing treatment for penile cancer using a 3D-printed high-dose-rate brachytherapy applicator.
Lee HHC; Chiu TD; Hrycushko B; Xiong Z; Hudak S; Woldu S; Mauck R; Corwin T; Meng X; Margulis V; Desai N; Folkert MR; Garant A
Brachytherapy; 2023; 22(5):580-585. PubMed ID: 37474438
[TBL] [Abstract][Full Text] [Related]
16. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
17. High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis.
Rouscoff Y; Falk AT; Durand M; Gal J; Chand ME; Gautier M; Marsaud A; Chevallier D; Amiel J; Hannoun-Levi JM
Radiat Oncol; 2014 Jun; 9():142. PubMed ID: 24941956
[TBL] [Abstract][Full Text] [Related]
18. High-dose rate brachytherapy in the treatment of penile carcinoma--first experience.
Petera J; Sirák I; Kašaová L; Mačingová Z; Paluska P; Zouhar M; Kutílek P; Brod'ák M; Vošmik M
Brachytherapy; 2011; 10(2):136-40. PubMed ID: 20702142
[TBL] [Abstract][Full Text] [Related]
19. Novel portable apparatus for outpatient high-dose-rate (HDR) brachytherapy in penile cancer.
Rishi A; Saini AS; Spiess PE; Yu A; Fernandez DC; Johnstone PAS; Naghavi AO
Brachytherapy; 2022; 21(6):839-847. PubMed ID: 35915039
[TBL] [Abstract][Full Text] [Related]
20. Penile brachytherapy: technical aspects and postimplant issues.
Crook J; Jezioranski J; Cygler JE
Brachytherapy; 2010; 9(2):151-8. PubMed ID: 19854685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]